Abstract
Genome sequencing (GS) has emerged as a powerful diagnostic tool in several patient populations. For example, in critically ill neonates, genetic disease often presents with few clinical features and disease progression can be rapid. Standard genetic testing strategies can take months or weeks to complete and many neonates die or are discharged before a diagnosis is obtained. Outside of China, application of rapid GS in critically ill infants has been shown to have both diagnostic and clinical utility.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
